The Royal Institution for the Advancement of Learning/ McGill University
发明人:
Saragovi, H. Uri
申请号：
AU2011253937
公开号：
AU2011253937A1
申请日:
2011.12.09
申请国别(地区):
AU
年份:
2012
代理人:
摘要：
#$%^&*AU2011253937A120120112.pdf#####Abstract The present invention relates to methods of treating or preventing retinal ganglion cell (RGC) death and/or glaucoma using modulators of neurotrophic receptors that comprise s-turn peptidomimetic cyclic compounds or derivatives thereof. The neurotrophic receptor modulators can be used alone, in combination and/or in conjunction with one or more other compounds, molecules or drugs that treat or prevent ocular hypertension, RGC death and/or glaucoma. C\NRPnrhilCC\\YniOQMO2 I DOC - R112/1 I
